NIH-funded research R01 grant

Understanding how ADAR1 protein interacts with Z-RNA in cells

Official title: Molecular recognition by ADAR1 of Z-RNA within transcriptomes

Funded at University of Houston · NIH-11100723 · Data updated 2026-11-12

This study is looking at how a protein called ADAR1 interacts with special RNA shapes called Z-RNA, which could help us understand how changes in RNA might play a role in diseases like Aicardi-Goutières syndrome, potentially offering new insights for patients.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Houston
NIH-funded
Lab location1 site (Houston, United States)
Project startSeptember 26, 2023
Project endJune 30, 2027
Funding year2024
Award (this year)$20,474
NIH project number3R01GM150642-02S1
Project IDNIH-11100723 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with neurological disorders, particularly those affected by Aicardi-Goutières syndrome or other autoimmune diseases.

Less likely to help

Patients with conditions unrelated to RNA editing or those not experiencing neurological symptoms may not benefit from this research.

What this research studies

This research investigates the role of the ADAR1 protein in recognizing Z-RNA structures within cellular RNA. It aims to understand how Z-RNA is formed, its prevalence in different RNA sequences, and how ADAR1 binds to these structures. By exploring these mechanisms, the research seeks to uncover the implications of RNA editing in diseases, particularly neurological disorders like Aicardi-Goutières syndrome. Patients may benefit from insights into how misediting of RNA contributes to disease processes.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for treating neurological diseases linked to RNA misediting.

How similar studies have gone: While the specific focus on Z-RNA and ADAR1 is relatively novel, previous research has shown that understanding RNA editing mechanisms can lead to significant advancements in treating related diseases.

Where this research is happening

  • University of Houston
    Houston, United States
    Active

Researchers

  • Principal investigator: Vicens, Quentin — University of Houston
  • Study coordinator: Vicens, Quentin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.